Home Cart Sign in  
Chemical Structure| 1243245-18-2 Chemical Structure| 1243245-18-2

Structure of GNF-6231
CAS No.: 1243245-18-2

Chemical Structure| 1243245-18-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GNF-6231 is a potent, selective, and orally bioavailable Porcupine inhibitor that blocks Wnt signaling.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GNF-6231

CAS No. :1243245-18-2
Formula : C24H25FN6O2
M.W : 448.49
SMILES Code : O=C(NC1=NC=C(N2CCN(C(C)=O)CC2)C=C1)CC3=CN=C(C4=CC(F)=NC=C4)C(C)=C3
MDL No. :MFCD30343851
InChI Key :AXXNRMISICMFNS-UHFFFAOYSA-N
Pubchem ID :46927297

Safety of GNF-6231

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Sca1+CD31−CD45− cells 100 nM 24 hours To evaluate the effect of GNF-6231 on the proliferation of Sca1+ cardiac progenitor cells. Results showed that WNT inhibition increased proliferation of Sca1+ cardiac progenitors. Cell Stem Cells Regen Med. 2016 Nov;2(2):10

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mouse MMTV-Wnt1 xenograft tumor model Oral 0.3, 1, 3 mg/kg Once daily for 2 weeks Evaluate the antitumor efficacy of GNF-6231 in the MMTV-Wnt1 tumor model, showing significant tumor growth inhibition at 0.3 mg/kg and tumor regression at 1 and 3 mg/kg ACS Med Chem Lett. 2016 May 10;7(7):676-80
C57Bl/6 mice Myocardial infarction model Intravenous injection 5 mg/kg Once daily for 6 days To evaluate the effect of GNF-6231 on cardiac function and remodeling post-MI. Results showed that GNF-6231 treatment significantly reduced the decline in cardiac function, prevented adverse cardiac remodeling, and reduced infarct size. Cell Stem Cells Regen Med. 2016 Nov;2(2):10

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.23mL

0.45mL

0.22mL

11.15mL

2.23mL

1.11mL

22.30mL

4.46mL

2.23mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories